Serum 25-Hydroxyvitamin D and Incidence of Fatal and Nonfatal Cardiovascular Events: A Prospective Study With Repeated Measurements

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4908-4915

  Perna, Laura ^a   Schottker B ^a   Holleczek, B ^b   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SAARLAND CANCER REGISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ADULT; AGED; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; GENERAL PRACTICE; GERMANY; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; REPEAT PROCEDURE; REVIEW; RISK ASSESSMENT; SURVIVAL TIME; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D 2; AGED; CALCIFEDIOL; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL ANALYSIS; VITAMIN D DEFICIENCY;

EID: 84889874128     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2424     Document Type: Review

References (31)

1. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819-829
2. Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS. Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011;19:192-201
3. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51:228-233
4. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analysis of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012;32:2794-2802
5. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013;73:38-47
6. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009;338:40-44
7. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185-197
8. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006;92: 39-48
9. Shoji T, Shinohara K, Kimoto E, et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2004;19:179-184
10. Lips P. VitaminDdeficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501
11. Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58:1433-1441
12. Garcia VC, Schuch NJ, Catania AS, Gouvea Ferreira SR, Martini LA. Parathyroid hormone has an important role in blood pressure regulation in vitamin D-insufficient individuals. Nutrition. 2013; 29:1147-1151
13. Schöttker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97:782-793
14. Semba RD, Houston DK, Bandinelli S, et al. Relationship of 25- hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010; 64:203-209
15. Ginde AA, Scragg R, Schwartz RS, Camargo CA. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J AmGeriatr Soc. 2009;57:1595-1563
16. Schöttker B, Jansen EH, Haug U, Schomburg L, Köhrle J, Brenner H. Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PlosOne. 2012;7:e48774
17. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:1931-1942
18. Shapses SA, Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA. 2011;305:2565-2566
19. Berry SD,NgoL, Samelson EJ, Kiel DP. Competing risk of death:An important consideration in studies of older adults. JAmGeriatr Soc. 2010;58:783-787
20. Raum E, Rothenbacher D, Löw M, Stegmaier C, Ziegler H, Brenner H. Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil. 2007;14:809-814
21. Schöttker B, Herder C, Müller H, Brenner H, Rothenbacher D. Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care. 2012;35:879-886
22. Slomski A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA. 2011;305:453-454, 456
23. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29: 1037-1057
24. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc. 1999;94:496-509
25. Geskus RB. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67:39-49
26. Heinze G. PSHREG - Proportional and non-proportional subdistribution hazards regression. Medical University of Vienna website. http://cemsiis. meduniwien.ac.at/en/kb/science-research/software/statistical-software/pshreg/. Accessed March 25, 2013
27. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr. 2010;91:82-89
28. WangTJ, Pencina MJ, Booth SL, et al. VitaminDdeficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511
29. Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 2013;59:381-391
30. Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012; 79:1397-1405
31. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011;58:374-382